In the placebo group, the samples receive placebo capsule containing starch ( 320 mg) up to 6 weeks twice daily ( 8 am and 8 pm ). All samples in both intervention and control groups, routinely receiv
Sponsors
Vice chancellor for research and technology, Tehran university of medical sciences
Conditions
Chronic kidney disease.
Kidney damage with moderately decreased GFR (30-59 mL/min)End stage renal disease.
End stage kidney disease: in allograft failure NOS on dialysis or without dialysis or transplant , Renal retinitis , Uraemic: apoplexia+ , dementia+ , neuropathy+ , paralysis+ , pericarditis